| Key Financial Ratios of Emmessar Biotech And Nutrition (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
0.61 |
1.48 |
0.99 |
0.94 |
2.88 |
|
| Diluted EPS (Rs.) |
0.61 |
1.48 |
0.99 |
0.94 |
2.88 |
|
| Cash EPS (Rs.) |
0.83 |
1.70 |
1.20 |
1.14 |
3.02 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
15.43 |
14.82 |
13.34 |
12.35 |
11.41 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
15.43 |
14.82 |
13.34 |
12.35 |
11.41 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
1.22 |
1.11 |
2.04 |
0.73 |
13.99 |
|
| PBDIT/Share (Rs.) |
2.11 |
1.82 |
2.12 |
2.05 |
4.63 |
|
| PBIT/Share (Rs.) |
1.92 |
1.63 |
1.94 |
1.86 |
4.51 |
|
| PBT/Share (Rs.) |
1.92 |
1.63 |
1.94 |
1.86 |
4.51 |
|
| Net Profit/Share (Rs.) |
0.63 |
1.50 |
1.01 |
0.95 |
2.90 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
172.95 |
163.94 |
104.05 |
280.54 |
33.07 |
|
| PBIT Margin (%) |
156.97 |
146.36 |
94.86 |
255.24 |
32.25 |
|
| PBT Margin (%) |
156.87 |
146.36 |
94.86 |
255.24 |
32.25 |
|
| Net Profit Margin (%) |
51.75 |
135.01 |
49.43 |
130.25 |
20.73 |
|
| Return on Networth / Equity (%) |
4.10 |
10.12 |
7.55 |
7.70 |
25.43 |
|
| Return on Capital Employed (%) |
10.96 |
9.86 |
12.85 |
13.53 |
35.20 |
|
| Return on Assets (%) |
3.42 |
8.57 |
6.34 |
6.58 |
18.57 |
|
| Total Debt/Equity (X) |
0.00 |
0.01 |
0.01 |
0.00 |
0.00 |
|
| Asset Turnover Ratio (%) |
0.07 |
0.07 |
0.13 |
0.05 |
1.00 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
15.67 |
13.56 |
14.14 |
14.73 |
3.85 |
|
| Quick Ratio (X) |
15.41 |
13.38 |
13.82 |
14.52 |
3.80 |
|
| Inventory Turnover Ratio (X) |
0.65 |
0.56 |
0.67 |
0.24 |
4.14 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
8.31 |
8.78 |
7.28 |
9.16 |
4.87 |
|
| EV/Net Operating Revenue (X) |
13.61 |
15.81 |
7.14 |
25.09 |
0.70 |
|
| EV/EBITDA (X) |
7.87 |
9.64 |
6.87 |
8.94 |
2.11 |
|
| MarketCap/Net Operating Revenue (X) |
24.86 |
26.74 |
12.16 |
37.65 |
1.05 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
1.97 |
2.01 |
1.86 |
2.23 |
1.29 |
|
| Price/Net Operating Revenue |
24.87 |
26.75 |
12.16 |
37.67 |
1.05 |
|
| Earnings Yield |
0.02 |
0.05 |
0.04 |
0.03 |
0.20 |
|
Source : Dion Global Solutions Limited
